Skip to content

Motivational and Cognitive Intervention for College Drinkers

Motivational and Cognitive Intervention for College Drinkers

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01204229
Acronym
MCID
Enrollment
100
Registered
2010-09-17
Start date
2010-05-31
Completion date
Unknown
Last updated
2011-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Consumption, Anxiety, Depression

Keywords

Alcohol Consumption, Social Anxiety, Depression, Brief Intervention, Motivational Interviewing, Cognitive Behavioral Therapy, Sub-Clinical Social Anxiety, Sub-Clinical Depression

Brief summary

In the proposed project the investigators will develop and test a novel brief intervention targeting college students who drink heavily to cope with anxiety and depression, a behavior that increases risk for the development of alcohol dependence.

Interventions

BEHAVIORALMotivational and Cognitive Intervention for Drinkers (MCID)

Integrate social anxiety/ depression and drinking intervention

Integrate drinking intervention

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

\- 1. At least 1 heavy drinking episode (4 or more drinks for women; 5 or more drinks for men). 2\. Sub-clinical anxiety or depression 3. Occasional to frequent drinking related problems

Exclusion criteria

* 1\. Clinical Axis I diagnosis 2. Current suicidal ideation, pregnancy, major medical illness, severe alcohol dependence, current hallucinations

Design outcomes

Primary

MeasureTime frame
Alcohol Consumption and Drinking-Related Negative ConsequencesPre-Treatment, 2-month follow-up, 4-month follow-up, 6-month follow-up
AnxietyPre-Treatment, 2-month follow-up, 4-month follow-up, 6-month follow-up
DepressionPre-Treatment, 2-month follow-up, 4-month follow-up, 6-month follow-up

Secondary

MeasureTime frame
Cost efficacy data2-3 months post completion

Countries

United States

Contacts

Primary ContactGiao Q. Tran, Ph.D.
Giao.Tran@uc.edu513-237-2608

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026